Early and Late Stage Venture Capital


    Abingworth has raised 12 funds dedicated to investing in life sciences and healthcare. Our most recent, Abingworth Bioventures 7 and Abingworth Clinical Co-Development Fund, raised $315 million and $108 million respectively and are actively investing.

    Our venture funds invest across our broad strategic areas of venture capital, clinical co-development, VIPEs and public markets. They focus primarily on private companies but invest a percentage of their value in public companies.